Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by Canadadaveon Nov 18, 2009 11:37am
485 Views
Post# 16499404

Speculating on this one

Speculating on this oneNew to HLO (not so much to the game in general ;) - if you could help with a bit of info consolidation, I'd be really grateful.

- Pinetree investment is really promising. I know PT really well, and they've a really good track record with this sort of thing - that's how I was turned on to HLO. Doesn't appear to be any insider knowledge there, and it's a really small play for them overall, but..

- Some good financing input lately as well, PT aside, though we're seeing more dilution. That's fine for now, but we're going to get to a point where investors aren't seeing good returns, even if the existing properties come in at anticipated levels. That brings me to the question:

What are we expecting right now in terms of announcements? I thought we should have seen something in or around the September/October timeframe, but nothing - just the sort of general "update" release in late September. Are we actually expecting to hear from them in any concrete way in the near future (not "I'm an investor, and I want to hear" - I know the answer to that, but rather "the company is due to report their results on XXX date").

At .05, I'm seeing slide to .04 by end of year without a positive news release, but fundamental support at 4 cents since they should now be able to fund moderate activity for a year. When you do the math with the higher number of shares out there, I'm thinking value of the minerals there under "neutral" projections is somewhere in the 15 cent range. (That investor report they have on their site is REALLY old, and is based on FAR less than the current numbers of shares outstanding). And that's BEFORE the cost of getting the stuff out of the ground, etc.

Not invested yet, so taking my time on this one - appreciate the insight anyone has.
<< Previous
Bullboard Posts
Next >>